Detailed information for compound 228185
Basic information
Technical information
- TDR Targets ID: 228185
- Name: (2E)-2-(2,3-dihydroinden-1-ylidene)acetamide
- MW: 173.211 | Formula: C11H11NO
-
H donors: 1
H acceptors: 1
LogP: 1.14
Rotable bonds: 1
Rule of 5 violations (Lipinski): 1 - SMILES: NC(=O)/C=C/1\CCc2c1cccc2
- InChi: 1S/C11H11NO/c12-11(13)7-9-6-5-8-3-1-2-4-10(8)9/h1-4,7H,5-6H2,(H2,12,13)/b9-7+
- InChiKey: LFYXPROOUKWVTO-VQHVLOKHSA-N
Network
Hover on a compound node to display the structore
Synonyms
- (2E)-2-indan-1-ylideneacetamide
- (2E)-2-(1-indanylidene)acetamide
- (2E)-2-(2,3-dihydroinden-1-ylidene)ethanamide
Targets
Known targets for this compound
No curated genes were found associated with this compound
Predicted pathogen targets for this compound
By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus multilocularis | glutamate receptor NMDA | 0.0177 | 0.1866 | 0.1866 |
| Schistosoma mansoni | glutamate receptor NMDA | 0.0238 | 0.5319 | 0.5 |
| Echinococcus granulosus | nmda type glutamate receptor | 0.0198 | 0.3037 | 0.1439 |
| Echinococcus multilocularis | nmda type glutamate receptor | 0.0321 | 1 | 1 |
| Echinococcus multilocularis | nmda type glutamate receptor | 0.0198 | 0.3037 | 0.3037 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| ED50 (functional) | = 9 mg kg-1 | Effective dose required for analgesic activity by trypsin-induced hyperalgesia assay at 20 mg/kg by oral administration in rats | ChEMBL. | 12540239 |
| ED50 (functional) | = 31 mg kg-1 | Effective dose required for muscle relaxation by intraperitoneal administration in mouse using Straub-tail (ST) assay | ChEMBL. | 12540239 |
| ED50 (functional) | = 31 mg kg-1 | Effective dose required for muscle relaxation by intraperitoneal administration in mouse using Straub-tail (ST) assay | ChEMBL. | 12540239 |
| ED50 (functional) | = 44 mg kg-1 | Effective dose required for muscle relaxation by intraperitoneal administration in mouse using Straub-tail (ST) assay | ChEMBL. | 12540239 |
| ED50 (functional) | = 108 mg kg-1 | Effective dose required for muscle relaxation by oral administration in mouse using Straub-tail (ST) assay. | ChEMBL. | 12540239 |
| ED50 (functional) | = 108 mg kg-1 | Effective dose required for muscle relaxation by oral administration in mouse using Straub-tail (ST) assay. | ChEMBL. | 12540239 |
| ED50 (functional) | = 164 mg kg-1 | Sedation caused by oral administration was estimated using rotorod (RR) assay. | ChEMBL. | 12540239 |
| ED50 (functional) | = 164 mg kg-1 | Sedation caused by oral administration was estimated using rotorod (RR) assay. | ChEMBL. | 12540239 |
| Inhibition (functional) | = 88 % | Percent inhibition for analgesic activity by trypsin-induced hyperalgesia assay at 20 mg/kg by oral administration in rats. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Effective dose required for muscle relaxation by oral administration in mouse using Straub-tail (ST) assay. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Sedation by oral administration was estimated using rotorod (RR) assay. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Ratio of rotorod to straub tail activity, which indicates the dose exhibiting muscle relaxant activity versus that producing sedation. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Antiinflammatory activity in cells by Carragenaan pleurisy assay by oral administration. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Antiinflammatory activity in edema by Carragenaan pleurisy assay by oral administration. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Percent inhibition for analgesic activity by trypsin-induced hyperalgesia assay at 20 mg/kg by oral administration in rats; ND is no data. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Effective dose required for analgesic activity by trypsin-induced hyperalgesia assay at 20 mg/kg by oral administration in rats. | ChEMBL. | 12540239 |
| ND (functional) | 0 | Antiinflammatory activity of the compound in cells by Carragenaan pleurisy assay by oral administration; ND means no data | ChEMBL. | 12540239 |
| ND (functional) | 0 | Antiinflammatory activity of the compound in edema by Carragenaan pleurisy assay by oral administration; ND means no data | ChEMBL. | 12540239 |
| Ratio (functional) | = 1.5 | Ratio of rotorod to straub tail activity, which indicates the dose exhibiting muscle relaxant activity versus that producing sedation | ChEMBL. | 12540239 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL130191
- PubChem: 10986759
Bibliographic References
1 literature reference was collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.